Caladrius Biosciences, Inc. (CLBS) financial statements (2021 and earlier)

Company profile

Business Address 110 ALLEN ROAD
BASKING RIDGE, NJ 07920
State of Incorp. DE
Fiscal Year End December 31
SIC 809 - Miscellaneous Health And Allied Services, Not (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:172338524722
Cash and cash equivalents171410 152019
Short-term investments   26  7
Other undisclosed cash, cash equivalents, and short-term investments 92826(10)(13)(4)
Restricted cash and investments      15
Receivables   0333
Other undisclosed current assets193691720(4)
Total current assets:35264461252936
Noncurrent Assets
Property, plant and equipment0000171716
Intangible assets, net (including goodwill)    91073
Goodwill    7725
Intangible assets, net (excluding goodwill)    2348
Other noncurrent assets1101111
Other undisclosed noncurrent assets   1   
Total noncurrent assets:1102272890
TOTAL ASSETS:362745635257126
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4669  10
Accounts payable1111  6
Accrued liabilities2458  4
Debt   0  1
Deferred revenue and credits   4
Other undisclosed current liabilities    20211
Total current liabilities:4669202116
Noncurrent Liabilities
Long-term debt and lease obligation    31114
Long-term debt, excluding current maturities    31114
Liabilities, other than long-term debt01246119
Deferred revenue and credits 5  
Deferred tax liabilities, net  1118
Other liabilities0124011
Other undisclosed noncurrent liabilities    202235
Total noncurrent liabilities:0124283468
Other undisclosed liabilities    (0)(21)(16)
Total liabilities:47713483468
Stockholders' equity
Stockholders' equity attributable to parent3221385152459
Preferred stock   0000
Common stock0000000
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital459439436433410396350
Accumulated other comprehensive income (loss)(0)0(0)(0) 00
Accumulated deficit(426)(417)(398)(382)(405)(372)(291)
Stockholders' equity attributable to noncontrolling interest(0)(0)(0)(0)(1)(0)(0)
Total stockholders' equity:3221375042358
TOTAL LIABILITIES AND EQUITY:362745635257126

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues   2352218
Revenue, net2   
Cost of revenue    (31)(20)(16)
Gross profit:   2422
Operating expenses(19)(20)(17)(28)(67)(136)(76)
Other undisclosed operating income (loss)   (2)312016
Operating loss:(19)(20)(17)(28)(31)(114)(58)
Nonoperating income (expense)011(0)(2)162
Other nonoperating income01100183
Interest and debt expense  (0)(0)(2)(2)(1)
Loss from continuing operations before equity method investments, income taxes:(19)(19)(16)(28)(35)(100)(56)
Other undisclosed income from continuing operations before income taxes  00221
Loss from continuing operations before income taxes:(19)(19)(16)(28)(33)(98)(56)
Income tax expense (benefit)11  12(0)170
Loss from continuing operations:(8)(19)(16)(16)(33)(81)(55)
Income from discontinued operations   38   
Net income (loss):(8)(19)(16)22(33)(81)(55)
Other undisclosed net income (loss) attributable to parent(0)(0)01  1
Net income (loss) attributable to parent:(8)(19)(16)23(33)(81)(55)
Other undisclosed net income available to common stockholders, basic    10 
Net income (loss) available to common stockholders, diluted:(8)(19)(16)23(33)(81)(55)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(8)(19)(16)22(33)(81)(55)
Other comprehensive income (loss)(0)0(0)(0)(0)(0)0
Comprehensive income (loss):(8)(19)(16)22(33)(81)(55)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(0)(0)0110(1)
Other undisclosed comprehensive income, net of tax, attributable to parent      1
Comprehensive income (loss), net of tax, attributable to parent:(8)(19)(16)23(33)(81)(55)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: